Redmond Asset Management’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-769
| Closed | -$131K | – | 155 |
|
|
2024
Q2 | $131K | Sell |
769
-118
| -13% | -$20.2K | 0.04% | 153 |
|
|
2024
Q1 | $381K | Sell |
887
-3
| -0.3% | -$1.29K | 0.12% | 130 |
|
|
2023
Q4 | $781K | Sell |
890
-29
| -3% | -$25.5K | 0.25% | 110 |
|
|
2023
Q3 | $861K | Buy |
919
+1
| +0.1% | +$937 | 0.31% | 104 |
|
|
2023
Q2 | $884K | Hold |
918
| – | – | 0.29% | 104 |
|
|
2023
Q1 | $1.03M | Hold |
918
| – | – | 0.35% | 96 |
|
|
2022
Q4 | $602K | Hold |
918
| – | – | 0.22% | 127 |
|
|
2022
Q3 | $774K | Sell |
918
-2
| -0.2% | -$1.69K | 0.29% | 113 |
|
|
2022
Q2 | $796K | Hold |
920
| – | – | 0.29% | 114 |
|
|
2022
Q1 | $1.4M | Buy |
920
+6
| +0.7% | +$9.12K | 0.42% | 83 |
|
|
2021
Q4 | $1.14M | Buy |
914
+3
| +0.3% | +$3.73K | 0.32% | 113 |
|
|
2021
Q3 | $1.11M | Buy |
911
+33
| +4% | +$40.1K | 0.35% | 95 |
|
|
2021
Q2 | $702K | Hold |
878
| – | – | 0.21% | 138 |
|
|
2021
Q1 | $508K | Buy |
+878
| New | +$508K | 0.16% | 154 |
|